Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    "Barraquer-Simons syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
"Barraquer-Simons syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting The BROADEN Study: A Study of Volanesorsen (Formerly ISIS-APOCIIIRx) in Patients With Partial Lipodystrophy
Condition: Partial Lipodystrophy
Interventions: Drug: volanesorsen;   Drug: Placebo
2 Recruiting CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy
Conditions: Familial Partial Lipodystrophy;   Nonalcoholic Steatohepatitis;   NAFLD
Intervention: Drug: Metreleptin
3 Enrolling by invitation Expanded Access Metreleptin Study
Condition: Familial Partial Lipodystrophy
Intervention: Drug: Metreleptin
4 Recruiting Familial Partial Lipodystrophy Study
Condition: Lipodystrophy, Familial Partial
Intervention: Other: High fat mixed meal
5 Completed Trial of Leptin Replacement Therapy in Patients With Lipodystrophy
Conditions: Hypoleptinemia;   Generalized Lipodystrophy;   Partial Lipodystrophy;   Insulin Resistance
Interventions: Drug: Leptin;   Drug: Placebo
6 Recruiting Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients
Condition: Familial Partial Lipodystrophy
Interventions: Drug: Obeticholic Acid;   Drug: Placebo
7 Enrolling by invitation Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
Conditions: Diabetes;   Lipodystrophy;   Hyperlipidemia
Intervention: Drug: Metreleptin
8 Recruiting Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label Extension
Condition: Lipodystrophy
Interventions: Drug: ISIS 304801;   Drug: Placebo
9 Recruiting Lipodystrophy Connect Patient Registry
Condition: Lipodystrophy
Intervention:

Indicates status has not been verified in more than two years